Heterogeneity of breast cancer subtypes and survival among Hispanic women with invasive breast cancer in California

[1]  A. Kurian,et al.  Age-specific incidence of breast cancer subtypes: understanding the black-white crossover. , 2012, Journal of the National Cancer Institute.

[2]  N. Gordon.  Socioeconomic factors and breast cancer in black and white Americans , 2003, Cancer and Metastasis Reviews.

[3]  C. Parise,et al.  Breast Cancer Subtypes as Defined by the Estrogen Receptor (ER), Progesterone Receptor (PR), and the Human Epidermal Growth Factor Receptor 2 (HER2) among Women with Invasive Breast Cancer in California, 1999–2004 , 2009, The breast journal.

[4]  L. Bernstein,et al.  Receptors, associations, and risk factor differences by breast cancer subtypes: positive or negative? , 2011, Journal of the National Cancer Institute.

[5]  A. Onitilo,et al.  Breast cancer subtypes based on ER/PR and Her2 expression: comparison of clinicopathologic features and survival. , 2009, Clinical medicine & research.

[6]  Christopher I. Li,et al.  Breast cancer characteristics and outcomes among Hispanic Black and Hispanic White women , 2012, Breast Cancer Research and Treatment.

[7]  C. Perou,et al.  Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. , 2006, JAMA.

[8]  E. Chang,et al.  Hidden breast cancer disparities in Asian women: disaggregating incidence rates by ethnicity and migrant status. , 2010, American journal of public health.

[9]  B. Popkin,et al.  Inequality in the Built Environment Underlies Key Health Disparities in Physical Activity and Obesity , 2006, Pediatrics.

[10]  C. Perou,et al.  Epidemiology of basal-like breast cancer , 2008, Breast Cancer Research and Treatment.

[11]  T. Church,et al.  Colorectal cancer deaths as determined by expert committee and from death certificate: a comparison. The Minnesota Study. , 1999, Journal of clinical epidemiology.

[12]  Anthony Rhodes,et al.  American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. , 2007, Archives of pathology & laboratory medicine.

[13]  Anthony Rhodes,et al.  American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  S. Narod,et al.  Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence , 2007, Clinical Cancer Research.

[15]  P. Porter,et al.  Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20–44 years of age , 2012, Breast Cancer Research and Treatment.

[16]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[17]  S. Glaser,et al.  Quality of birthplace information obtained from death certificates for Hispanics, Asians, and Pacific Islanders. , 2004, Ethnicity & disease.

[18]  P. Braveman,et al.  Socioeconomic Status and Breastfeeding Initiation among California Mothers , 2006, Public health reports.

[19]  Nclr.  The Hispanic Population , 2003 .

[20]  N. Gordon.  Association of education and income with estrogen receptor status in primary breast cancer. , 1995, American journal of epidemiology.

[21]  William D Mosher,et al.  Fertility, contraception, and fatherhood: data on men and women from cycle 6 (2002) of the 2002 National Survey of Family Growth. , 2006, Vital and health statistics. Series 23, Data from the National Survey of Family Growth.

[22]  R. Cress,et al.  Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotype , 2007, Cancer.

[23]  Scarlett L. Gomez,et al.  Quality of cancer registry birthplace data for Hispanics living in the United States , 2005, Cancer Causes & Control.

[24]  A. Drewnowski,et al.  Poverty and obesity: the role of energy density and energy costs. , 2004, The American journal of clinical nutrition.

[25]  William A Satariano,et al.  Hospital policy and practice regarding the collection of data on race, ethnicity, and birthplace. , 2003, American journal of public health.

[26]  C R Key,et al.  Biologic characteristics of interval and screen-detected breast cancers. , 2000, Journal of the National Cancer Institute.

[27]  Scarlett L. Gomez,et al.  Misclassification of race/ethnicity in a Population-based Cancer Registry (United States) , 2006, Cancer Causes & Control.

[28]  P. Porter,et al.  Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. , 2000, Journal of the National Cancer Institute.

[29]  R. Prentice,et al.  Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer. , 2011, Journal of the National Cancer Institute.

[30]  C. Percy,et al.  The accuracy of liver cancer as the underlying cause of death on death certificates. , 1990, Public health reports.

[31]  D. Rose,et al.  The influence of socioeconomic disparities on breast cancer tumor biology and prognosis: a review. , 2009, Journal of women's health.

[32]  W. Willett,et al.  Carotenoid intakes and risk of breast cancer defined by estrogen receptor and progesterone receptor status: a pooled analysis of 18 prospective cohort studies. , 2012, The American journal of clinical nutrition.

[33]  M. Rossing,et al.  Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients , 2007, Breast Cancer Research.

[34]  S. Ooi,et al.  Disparities in breast cancer characteristics and outcomes by race/ethnicity , 2011, Breast Cancer Research and Treatment.

[35]  I. Jatoi,et al.  Socioeconomic disparities and breast cancer hormone receptor status , 2012, Cancer Causes & Control.

[36]  W. Willett,et al.  Fruit and vegetable intake and risk of breast cancer by hormone receptor status. , 2013, Journal of the National Cancer Institute.

[37]  T. Byers,et al.  Ethnic disparities in breast tumor phenotypic subtypes in Hispanic and non-Hispanic white women. , 2011, Journal of women's health.

[38]  P. Porter,et al.  Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers. , 1999, Journal of the National Cancer Institute.

[39]  G. Hobbs,et al.  Triple-Negative Breast Cancer and Obesity in a Rural Appalachian Population , 2008, Cancer Epidemiology Biomarkers & Prevention.

[40]  Charles F. Lynch,et al.  Quality of race, Hispanic ethnicity, and immigrant status in population-based cancer registry data: implications for health disparity studies , 2007, Cancer Causes & Control.

[41]  A. P. Ortiz,et al.  Breast cancer molecular subtypes and survival in a hospital-based sample in Puerto Rico , 2013, Cancer medicine.

[42]  Dongfeng Zhang,et al.  Physical activity and risk of breast cancer: a meta-analysis of prospective studies , 2013, Breast Cancer Research and Treatment.